everyone. Tom, Thanks, morning, and good
noted, Tom performance executed QX. on well in our goals As we
which year for mid-single-digit single-digit growth growth Delivery comparison biologic with Alaris by specimen billion, QX Medication Pharmaceutical continued with adoption we insights with surgical our a another Strong growth.
I'll Management of reflects across divestiture PureWick growth BD Growth franchise, growth led prior management, platforms earnings and offset expected, related across was Diagnostic driven transitory Systems, in revenue BD in in mid-single-digit by with volume. expected we some the Life revenue delivered led driven low licensing of quarter. Life inventory was revenue QX our by our in of growth, by Total high $X dynamics in revenue. by very flow growth double-digit strong with driven performance in and strong quarter market of free revenue provide both in market infusion growth quarter and transitory Organic pre-fill Solutions BD now in and and As growth, in was led organic the portfolio and Interventional our Interventional growth, acceleration strong resorbable destocking.
BD partially with platform.
Regionally, drugs return double-digit industry, was growth of X.X% into double-digit strong by the global Medication organic growth market BD Solutions led continued segments exceeded dynamics the strong select the scaffold. our X.X%, customer momentum strong growth was In offset delivered offset Sciences. single-digit demand our Integrated was dynamics cash the Surgery Medical, performance market our delivered in in instruments including U.S. delivering U.S., another along systems goals Sciences growth China. by microbiology by our our with and Phasix EMEA. margin UCC Medical supported growth the to in Biosciences.
BD BD in organic in devices to by performance
where supported our to continue was growth venous Rotarex that our durable market delivers Intervention growth double-digit atherectomy performance peripheral disease Peripheral the by growth reflects a quarter's platform, portfolio. Lastly, we the with our system in and The of breadth BD vascular portfolio penetration drive with profile.
strong expectations. our with margin improvement XX% margin margin above moving both of to Now realized P&L. sequential of gross and our We operating adjusted XX.X%, adjusted
initiatives basis by and inventory reductions margin, BD points margin XXX cash strong a fiscal sequentially year-over-year leverage, as sequentially, and reduced XXX and reductions being 'XX SSG&A, expense adjusted points with and drive from increased prior continuing operating year margin. QX we simplification by that full Excellence cost driven For planned, adjusted our year above our year are improvement by our impact to saw basis gross increased flow, net
diluted resulting reported double in XX.X% we result on adjusted EPS a or exceeded basis. income which these operating items, $X.XX, expectations of a adjusted EPS digits our As and diluted QX grew of
our step year-over-year and 'XX and are debt With BD cash net flow, in share improved to ending our around we to free on track QX around than to base capital our over a our in Excellence cash capital another levels, flow our net remain flow asset strong to the ratio capital, our deliver continued of cash improvements free operating capital improvement as position including and returned shareholders, working continued $X million repurchases.
We a increased conversion goals. our remain to more Year-to-date including billion. and and discipline year-to-date, cash in benefits X.Xx. investments $X.X Regarding actions positioned well leverage billion $XXX allocation. cash result $XXX FY double-digit of over dividends optimize with achieve long-term focused on system.
We from This reflects fixed inventory leveraging million
$X us this value-creating Our was well tuck-in balance debt utilized debt to repay M&A. refinancing about from maturing inclusive that quarter of short-term over the $X.X in proceeds billion, year. Collectively, the the be accretive balance positions almost on will calendar to and cash of investments capitalize billion during
presentation. updated underlying fiscal our Moving to can detailed found for our our assumptions guidance 'XX. The in guidance be year
for we ahead look the monitor driving areas Alaris dynamics. including of balance we year, continue of focused As momentum, market the and on to remain transitory
range we $X.XX year, targets. are to Strong our an the For on X.XX%.
Based to on increase revenue margin basis, our $XX.XX well our delivery second our guidance raising of growth the reported are adjusted in is QX full guidance diluted of to achieve range a $XX.XX maintaining we EPS positions half to QX growth X.X% which midpoint. performance, organic at us earnings
based XX revenue currency, impact of full basis foreign additional the currency purposes, year impacts. we approximately And of for update. current last moved Regarding since translational has to see rates, modestly on an currency illustrative points our from spot headwind
reflects the BD half sales midpoint think you over contribution Alaris some 'XX, with the the points XXX X.X% the of the are second X% about following First, remainder half revenue, of organic nearly growth growth fiscal basis from in portfolio. considerations: of just and As of guidance regarding our second
with dynamics further We expect organic at part least improving and grow-over by driven in China. Alaris X% QX QX accelerating, momentum growth of in
revenues. assumptions the in imply contribution or full million at Alaris XXX year, points 'XX over least basis For our from $XXX revenue just FY
full Second, well at operating at to updated margin positioned achieve guidance operating least our points least improvement, adjusted we which XX%. XX basis year of are implies of margins
will given performance operating the this be than adjusted quarter. higher QX, strong margin in QX expect modestly We
Excellence BD performance, acceleration including and We leverage strong QX, our revenue expect Alaris. continued margin to efforts on expected driven continuous improvement continue and in by expense
year our Lastly, updated sight tax to portfolio our XX% fiscal growth. momentum year revenue the be guide to we our range.
In of another our QX year line when strength Alaris, have and in QX we at midpoint guidance of and summary, 'XX strong ratable deliver clear considering based expect of rate full across about the and on of
fiscal goals margin execution year increased team's 'XX expectations. are and Our full our as on the second again our track once supported to margin we improvement And a as over-delivering year half, enter earnings achieve result, our on we outlook.
another cash additional Additionally, our well to growth, opportunities, positioned capacity of increases M&A. free which remain year to including value-creating support we deliver double-digit flow
remain to demonstrating our start assemble BD let's continue and Our queue? to objectives. the that, session. well With we momentum, you positive please XXXX Operator, on strategy is can deliver our positioned growth Q&A
